The study was reformed on LPS-induced mice by supplementing them for 14 days at 35 mg/kg/day body weight of curcuminoids as CurQfen. Results showed the genes which significantly upregulate during various cancer types got down regulated and vice versa. Similarly, many of the genes differentially expressed in various chronic inflammatory conditions, obesity, cardiovascular diseases and liver steatosis were also reportedly modulated by treatment with the ingredient. The company says this evidence points to a protective role for this ingredient in the prevention and treatment of multiple chronic disease

Nutraceutical business review article about the study